本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (1963)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 27, 2024 (publication date) through May 26, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Marrapu S, Kumar R. Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return. World J Hepatol 2024; 16(10): 1151-1157 [PMID: 39474571 DOI: 10.4254/wjh.v16.i10.1151] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v16/i10/1151.htm |
| 编号 | Citing Articles |
| 1 |
Qun Wan, Xiaolin Yu, Jinyu Huang, Liting Yang, Deqiang Wang, Hua Zhou, Gongming Zhang, Shenglan Mao, Yanmeng Chen, Zhenlin Zhang, Jie Wei. An Investigative Study of LGALSL and HLA‐DRB1 as Prognostic Biomarkers and Therapeutic Targets in Chronic Hepatitis B Patients With Persistent HBV DNA Viremia Under Entecavir Treatment. Journal of Medical Virology 2025; 97(4) doi: 10.1002/jmv.70329
|